Important role played by nurse helplines

A survey by Cancer Research UK's helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.

More than half of respondents in a survey of Cancer Research UK's telephone helpline and email service users said that they sought information to have a specific question answered (63 per cent) and to cope with and understand their situation more clearly (46 per cent). Only a small number of people cited a need for information to make decisions (11 per cent).

These findings emphasised the important role played by Cancer Research UK and other helplines to answer patients' questions to help them understand their situation more clearly.

Martin Ledwick, Cancer Research UK's head information nurse, said: "It's incredibly important that patients can make informed decisions. It's easy to assume that people with cancer ask for information mainly to help them do this. But this survey showed that many people who contact us have a fundamental need to understand their situation which is not related to making a choice."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients